WealthStone Inc. Buys 3,947 Shares of Johnson & Johnson (NYSE:JNJ)

Share on StockTwits

WealthStone Inc. grew its stake in shares of Johnson & Johnson (NYSE:JNJ) by 38.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,134 shares of the company’s stock after acquiring an additional 3,947 shares during the quarter. Johnson & Johnson comprises approximately 1.0% of WealthStone Inc.’s portfolio, making the stock its 15th biggest position. WealthStone Inc.’s holdings in Johnson & Johnson were worth $2,104,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Winslow Evans & Crocker Inc. lifted its position in shares of Johnson & Johnson by 0.3% during the 2nd quarter. Winslow Evans & Crocker Inc. now owns 21,603 shares of the company’s stock valued at $3,037,000 after buying an additional 69 shares in the last quarter. Lathrop Investment Management Corp lifted its position in shares of Johnson & Johnson by 1.4% during the 2nd quarter. Lathrop Investment Management Corp now owns 4,901 shares of the company’s stock valued at $689,000 after buying an additional 69 shares in the last quarter. Reik & CO. LLC lifted its position in shares of Johnson & Johnson by 0.4% during the 2nd quarter. Reik & CO. LLC now owns 17,727 shares of the company’s stock valued at $2,493,000 after buying an additional 70 shares in the last quarter. Delta Investment Management LLC lifted its position in shares of Johnson & Johnson by 1.0% during the 2nd quarter. Delta Investment Management LLC now owns 7,406 shares of the company’s stock valued at $1,041,000 after buying an additional 71 shares in the last quarter. Finally, IFG Advisory LLC lifted its position in shares of Johnson & Johnson by 0.4% during the 2nd quarter. IFG Advisory LLC now owns 16,170 shares of the company’s stock valued at $2,274,000 after buying an additional 71 shares in the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

In related news, EVP Kathryn E. Wengel sold 16,115 shares of the business’s stock in a transaction on Wednesday, September 2nd. The stock was sold at an average price of $153.52, for a total transaction of $2,473,974.80. Following the completion of the transaction, the executive vice president now owns 66,658 shares in the company, valued at approximately $10,233,336.16. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.27% of the stock is owned by insiders.

NYSE JNJ opened at $146.36 on Friday. The company has a market cap of $385.30 billion, a P/E ratio of 23.01, a P/E/G ratio of 3.04 and a beta of 0.69. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.48. The business’s 50 day moving average price is $145.51 and its 200-day moving average price is $146.57. Johnson & Johnson has a fifty-two week low of $109.16 and a fifty-two week high of $157.00.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Sunday, October 18th. The company reported $2.20 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.98 by $0.22. Johnson & Johnson had a return on equity of 34.64% and a net margin of 21.01%. The company had revenue of $21.08 billion during the quarter, compared to analysts’ expectations of $20.15 billion. During the same quarter in the previous year, the business earned $2.12 EPS. Johnson & Johnson’s revenue was up 1.7% compared to the same quarter last year. As a group, equities analysts predict that Johnson & Johnson will post 7.99 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 24th will be issued a dividend of $1.01 per share. This represents a $4.04 dividend on an annualized basis and a yield of 2.76%. The ex-dividend date is Monday, November 23rd. Johnson & Johnson’s payout ratio is currently 46.54%.

A number of research analysts have recently weighed in on the company. Stifel Nicolaus cut Johnson & Johnson from a “buy” rating to a “hold” rating in a research report on Wednesday, August 19th. Credit Suisse Group lifted their target price on Johnson & Johnson from $163.00 to $168.00 and gave the company an “outperform” rating in a research note on Wednesday, October 14th. ValuEngine raised Johnson & Johnson from a “sell” rating to a “hold” rating in a research note on Monday, August 3rd. Cantor Fitzgerald lifted their price objective on Johnson & Johnson from $168.00 to $180.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 14th. Finally, Raymond James reaffirmed a “buy” rating on shares of Johnson & Johnson in a research note on Friday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and ten have issued a buy rating to the company’s stock. Johnson & Johnson presently has an average rating of “Buy” and a consensus price target of $164.93.

About Johnson & Johnson

Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR.

Read More: Are we seeing the beginning of a new bubble?

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Lord Abbett & CO. LLC Raises Stock Holdings in Xilinx, Inc.
Lord Abbett & CO. LLC Raises Stock Holdings in Xilinx, Inc.
Xilinx, Inc.  Shares Acquired by Banco Bilbao Vizcaya Argentaria S.A.
Xilinx, Inc. Shares Acquired by Banco Bilbao Vizcaya Argentaria S.A.
Lord Abbett & CO. LLC Boosts Holdings in Xilinx, Inc.
Lord Abbett & CO. LLC Boosts Holdings in Xilinx, Inc.
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Raises Stake in Xilinx, Inc.
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Raises Stake in Xilinx, Inc.
Andra AP fonden Boosts Stock Holdings in Tractor Supply
Andra AP fonden Boosts Stock Holdings in Tractor Supply
Andra AP fonden Buys 1,200 Shares of The Travelers Companies, Inc.
Andra AP fonden Buys 1,200 Shares of The Travelers Companies, Inc.


 
© 2006-2020 Zolmax.